Beam Therapeutics Inc.
BEAM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$377 | -$133 | -$289 | -$371 |
| Dep. & Amort. | $22 | $20 | $14 | $7 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $121 | $99 | $84 | $44 |
| Change in WC | -$110 | -$116 | $252 | $111 |
| Other Non-Cash | -$3 | -$19 | -$38 | $142 |
| Operating Cash Flow | -$347 | -$149 | $23 | -$66 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$34 | -$49 | -$47 |
| Net Acquisitions | $0 | $0 | $412 | $1 |
| Inv. Purchases | -$486 | -$984 | -$1,617 | -$777 |
| Inv. Sales/Matur. | $680 | $1,090 | $1,205 | $529 |
| Other Inv. Act. | $0 | $0 | -$412 | $0 |
| Investing Cash Flow | $185 | $72 | -$461 | -$294 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$2 | -$2 | -$2 |
| Stock Issued | $8 | $270 | $108 | $757 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $9 | $6 | $1 |
| Financing Cash Flow | $8 | $276 | $112 | $756 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$155 | $199 | -$327 | $396 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $445 | $246 | $573 | $177 |
| End Cash | $290 | $445 | $246 | $573 |
| Free Cash Flow | -$356 | -$183 | -$26 | -$113 |